With both the discount rate and future P/E ratio remaining effectively unchanged, analysts have kept their price target for Oncoclínicas do Brasil Serviços Médicos steady at R$4.49.
What's in the News
- Oncoclínicas do Brasil Serviços Médicos S.A. was removed from the Brazil IBRX Index.
- A Special/Extraordinary Shareholders Meeting is scheduled at the São Paulo headquarters.
Valuation Changes
Summary of Valuation Changes for Oncoclínicas do Brasil Serviços Médicos
- The Consensus Analyst Price Target remained effectively unchanged, at R$4.49.
- The Discount Rate for Oncoclínicas do Brasil Serviços Médicos remained effectively unchanged, moving only marginally from 21.46% to 21.65%.
- The Future P/E for Oncoclínicas do Brasil Serviços Médicos remained effectively unchanged, moving only marginally from 49.25x to 49.48x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.